Lates News

According to AI Fast News on August 25th, Open Source Securities issued a research report giving a buy rating to OPENMED (300633.SZ). The rating reasons mainly include: 1) Rich product pipeline with innovative research and development, dual-wheel drive of endoscopy + ultrasound business, rapid release of IVUS performance; 2) Accelerated penetration in the high-end domestic market, deepening of overseas localization to help expand new products. (Daily Economic News)